Countering Hesitancy and Misinformation on Side Effects to Complete the Course of COVID Vaccination

It has been well-documented that concerns about side effects prevent many from soliciting immunization. And family medicine providers play a key role in addressing concerns about COVID vaccines. However, there are few documented examples of the decision-making process regarding second shots after the emergence of a concerning and previously unknown side effect. Therefore, we present a case where a primary care provider and patient worked together to analyze real-time adverse event data on post-vaccination shingles to decide whether to receive the second dose

Xylazine is Different - Handout for NC General Assembly Select Committee on Substance Abuse

Handouts for testimony on xylazine on March 13, 2024

Meta-analysis of heterogeneity

Meta-analyses Applying a Food and Drug Administration (FDA) method for opioid measurement dilemmas, we used meta-analytic techniques to quantify how much heterogeneity would have been observed across hypothetical state-comparison studies, each applying one of the 4 variants on the same sample (fixed effects). In preliminary analyses, Florida generally had higher opioid use than California, presumably due to an older population, scope of practice legislation and other factors

Street Drugs in North Carolina - Randolph County - January 2024

Presentation to the Randolph County on the local drug supply

Overview of Evaluating ADFs in the Community

Dr. Nabarun Dasgupta presents as the invited Guest Speaker at the US Food and Drug Administration Advisory Committee on the 10 year evaluation of OxyContin reformulation. Epidemiologic considerations on evaluation of abuse deterrent formulations are presented. Presented June 10, 2020 at the Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSARM) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) https://www.fda.gov/advisory-committees/advisory-committee-calendar/september-10-11-2020-joint-meeting-drug-safety-and-risk-management-advisory-committee-and-anestheti

Days’ Supply Assignment for Opioid Analgesics - Code and Jupyter Notebook

Code and output to accompany paper in Journal of Pharmacy Practic

The Case for Product-Specific Surveillance

There is no abstract associated with this publication

Ghost in the Machine: The Emotional Gravity of Conducting Mortality Research

There is no abstract associated with this publication